How Has GISAID Contributed to the COVID-19 Pandemic Response?
During the COVID-19 pandemic, GISAID has been a critical resource for tracking the SARS-CoV-2 virus. The platform has enabled researchers to monitor the emergence of new variants, such as the Delta and Omicron variants, and to study their transmission dynamics and impact on vaccine efficacy. By providing real-time data, GISAID has facilitated the rapid development of diagnostic tests, vaccines, and therapeutic options. It has also supported global surveillance efforts, helping to inform public health policies and containment strategies.
